New AI-based analysis method can accurately classify and monitor brain tumors is drawing significant interest across the industry.
An international research team, with significant involvement from the Medical University of Vienna, has developed a new AI-based analysis method that can accurately classify brain tumors using genetic material from cerebrospinal fluid (CSF) and monitor the progression of the disease.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →